arrow_back Back to App

Funding Research for New Traumatic Brain Injury Treatments for Veterans

This Act authorizes $60 million over three years (2026-2028) for the Department of Veterans Affairs (VA) to establish grant programs focused on TBI research. The goal is to fund clinical trials and develop innovative neurorehabilitation treatments, including non-pharmacological therapies, for veterans suffering from chronic mild TBI (mTBI). This initiative aims to improve veterans' mental health outcomes, reduce suicide risk, and establish standards of care.
Key points
Authorization of $60 million for fiscal years 2026-2028 dedicated to research and treatment development for chronic mild Traumatic Brain Injury (mTBI) in veterans.
Creation of two grant programs supporting the testing of novel, patient-centered therapies, including non-pharmacological approaches.
Mandate for clinical studies to measure the effectiveness of funded treatments in improving veterans' mental health and reducing suicidality.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_6993
Sponsor: Rep. Bergman, Jack [R-MI-1]
Process start date: 2026-01-09
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

BEACON Act of 2026

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_6993.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2026-01-09.

What are the main provisions?

Key points include:

  • Authorization of $60 million for fiscal years 2026-2028 dedicated to research and treatment development for chronic mild Traumatic Brain Injury (mTBI) in veterans.
  • Creation of two grant programs supporting the testing of novel, patient-centered therapies, including non-pharmacological approaches.
  • Mandate for clinical studies to measure the effectiveness of funded treatments in improving veterans' mental health and reducing suicidality.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Bergman, Jack [R-MI-1].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Veterans' Affairs.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-24.

CATEGORIES

Health Public Investments